The nomination committee is a shareholders’ committee that has responsibility for nominating directors to be appointed at the annual shareholders’ meeting.
According to the Swedish Corporate Governance Code, the nomination committee is required to have at least three members, the majority of which must not be members of the board of directors. In addition, the chairman of the nomination committee is not permitted to be a member of the board of directors and the managing director or other company managers are not permitted be members of the nomination committee.
The nomination committee is to propose candidates for the post of chair and other members of the board of directors, as well as fees and other remuneration to each member of the board of directors. The nomination committee is also to present proposals on the election and remuneration of the statutory auditor. Such recommendations shall be presented at the annual shareholders’ meeting.
The shareholders’ meeting is to appoint members of the nomination committee or to specify how they are to be appointed.
At the Annual General Meeting on May 9, 2019 it was resolved that Swedish Orphan Biovitrum AB (publ) shall have a nomination committee consisting of four members, the Chairman of the Board of Directors and one representative for each of the the three largest shareholders in the Company based on shareholder statistics from Euroclear Sweden AB as per the last banking day in August.
The Annual General Meeting 2019 adopted Instruction & Charter for the Nomination Committee that includes the tasks of the Nomination Committee and the procedure for appointing its members. The instruction applies until the General Meeting of shareholders resolve otherwise. The document is available for download on this page.
The composition of the Nomination Committee for the 2020 Annual General Meeting was made public on October 25, 2019.
The nomination committee of the Annual General Meeting on May 13, 2020 consists of:
- Petra Hedengran, appointed by Investor AB
- Lennart Francke, appointed by Swedbank Robur Fonder AB
- Anders Oscarsson, appointed by AMF & AMF Fonder
- Håkan Björklund, as Chairman of the Board of Swedish Orphan Biovitrum AB (publ)
For information to shareholders on how to submit proposals to the Nomination Committee, please follow this link.